Lack of magnetic resonance imaging lesion activity as a treatment target in multiple sclerosis: An evaluation using electronically collected outcomes

Article ID	Journal	Published Year	Pages	File Type
5912098	Multiple Sclerosis and Related Disorders	2016	6 Pages	PDF

Abstract

We did not find a short-term benefit of changing DMT to pursue MRI stability.

Keywords

PHQ9 standardized difference T25FW Patient Health Questionnaire 9 Relapsing-remitting MS RRMs EQ-5D DMT DMF MRI standard deviation interferon IFN Database patient reported outcomes Magnetic resonance imaging GDE disease modifying therapy dimethyl fumarate subcutaneous Intramuscular mycophenolate mofetil Multiple sclerosis NEDA No evidence of disease activity glatiramer acetate

Related Topics

Life Sciences Biochemistry, Genetics and Molecular Biology Genetics

Lack of magnetic resonance imaging lesion activity as a treatment target in multiple sclerosis: An evaluation using electronically collected outcomes

Authors

Devon S. Conway, Nicolas R. Thompson, Jeffrey A. Cohen,